The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

People today have many more options to help with obesity. If you are interested in trying an anti-obesity medication, talk with a doctor. GLP-1 drugs are becoming increasingly popular for their ...

Nearly half of individuals consuming alcohol at baseline reduced their alcohol consumption following the initiation of AOMs.

New research found that some anti-obesity medications such as Wegovy and Zepbound may prompt people to drink less. These ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

As anti-obesity medications gain popularity ... with over 12% of the population having tried the medication at least once, and probably at least 6% of the people currently with a prescription ...

Now, research from Henry Ford Health, has found that weight-loss drugs, including GLP-1, could also impact alcohol ...

Anti-obesity medications linked to reduced alcohol ... Study: Alcohol Use and Antiobesity Medication Treatment. Image Credit: PeopleImages.com - Yuri A / Shutterstock.com In a recent study ...

Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...

“[Friday’s] decision likely opens the door to Medicare coverage of an anti-obesity medication a bit wider than when the FDA approved Wegovy for cardiovascular disease risk reduction early in ...